AHSC - Imperial College Academic Health Science Centre ☰ Menu
  • About Imperial College AHSC
    • The AHSC Partners
    • How we work
    • Our history
    • Our Impact
    • Imperial College Health Partners
  • Our Vision and Strategy
  • Research Disease Areas
    • Cancer
    • Infection and antimicrobial resistance
    • Cardiovascular
    • Lung disease
    • Metabolic Medicine
    • Neurological and neurodegenerative disease
  • Education and Learning
  • AHSC Seminars
  • News & Events
  • Contact us
Search
  • About this site
  • Cookies policy

© 2022 Imperial College Academic Health Science Centre

Imperial College Academic Health Science Centre

Home » News » Statins slow the progression of advanced multiple sclerosis in clinical trial

Statins slow the progression of advanced multiple sclerosis in clinical trial

  • Share
  • Share on Twitter
  • Share on Facebook
  • Share on LinkedIn

Related News

March 1, 2017 Seminar Series 2017 – The role of the Microbiome in Gastrointestinal Cancers   Bacteria that live inside our bodies – known as the microbiome – have become a hot topic in biomedical science over the last few years, with an increasing amount of evidence to suggest they play central roles in health and disease. In this seminar two experts will discuss the role of the microbiome in […]
May 9, 2018 The virus-killing ‘bodyguards’ that make lupus worse
January 6, 2020 How safe are e-cigarettes?